方法：回顾性分析32例局部晚期乳腺癌患者进行新辅助化疗的临床资料。
Methods: 32 patients with locally advanced breast cancer treated by neoadjuvant chemotherapy were reviewed retrospectively.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
目的评价CEF方案新辅助化疗治疗局部晚期乳腺癌的临床疗效和毒性反应。
Objective to evaluate the clinical efficacy and toxicity of CEF as the neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer (LABC).
因此努力提高局部晚期乳腺癌的早诊断，做到早治疗是提高局部晚期乳腺癌生存率的关键。
Therefore, improving the earlier diagnosis to give the earlier treatment is the key point to improve the survival rates of locally advanced breast cancer.
术前辅以新辅助化疗，术后辅以正规内分泌治疗是提高局部晚期乳腺癌生存率的必要手段。
The neoadjuvant chemotherapy and regular endocrine therapy are the necessary measures to improve the survival rates of locally advanced breast cancer.
单因素分析表明：临床分期、肿瘤大小是局部晚期乳腺癌的生存指标。
Univariate analysis found that the size of tumor, TNM stage were related to survival rates.
单因素分析表明：临床分期、肿瘤大小是局部晚期乳腺癌的生存指标。
Univariate analysis found that the size of tumor, TNM stage were related to survival rates.
应用推荐